RF – Updated Overview and Approaches to the Management of the Main Psychodermatological Disorders

Introduction Medical students have a high academic load that interferes not only academically but also with their perception of satisfaction with their self-performance, such as sleep quality, non-medical social activities, mental health, and others. This […]

Oral roflumilast is a phosphodiesterase-4 inhibitor approved for the prevention of exacerbations of chronic obstructive pulmonary disease and chronic bronchitis. In dermatology, topical roflumilast is authorized by the US Food and Drug Administration for the […]

Background and objective The burden of nonvenereal infections in Spanish dermatology practice has not yet been evaluated. The aim of this study was to analyze the overall weight of these infections in outpatient dermatology caseloads. […]